|
시장보고서
상품코드
2051054
심장 바이오마커 시장 : 제품 유형별, 용도별, 검사 시행 장소별, 지역별Cardiac Biomarkers Market, By Product Type, By Application, By Location of Testing, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
심장 바이오마커 시장은 2026년에 194억 9,000만 달러로 추정되며, 2033년까지 478억 7,000만 달러에 이를 것으로 예상되고 있습니다. 또한 2026-2033년 CAGR 13.7%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도 : | 2025년 | 2026년 시장 규모 : | 194억 9,000만 달러 |
| 과거 데이터 기간 : | 2020-2024년 | 예측 기간 : | 2026-2033년 |
| 예측 기간(2026-2033년) CAGR : | 13.70% | 2033년 시장 규모 예측 : | 478억 7,000만 달러 |
심장 바이오마커는 심장 근육이 손상되거나 스트레스를 받았을 때 혈액 속에 존재하는 단백질을 말합니다. 이들은 다양한 심장 질환을 감지하고 모니터링하는 데 도움이 됩니다. 심장 바이오마커 시장은 심혈관 질환 발생률 증가와 심장 질환에 취약한 노년층 증가를 배경으로 최근 몇 년 동안 괄목할 만한 성장세를 보이고 있습니다. 또한, 기술의 발전으로 보다 민감한 바이오마커가 개발되어 심장질환을 조기에 발견할 수 있게 되었습니다.
시장 역학:
세계 심장 바이오마커 시장은 고령 인구 증가, 심혈관 질환으로 인한 경제적 부담 증가, 현장 진료 검사의 보급 확대, 지속적인 연구개발에 힘입어 성장하고 있습니다. 그러나 새로운 심장 바이오마커의 승인에 대한 규제 문제, 인지도 부족, 그리고 새로운 기술에 대한 수용성 지연은 시장 관계자들에게 도전이 되고 있습니다. 한편, 의료비 증가, 당뇨병 및 생활습관병 부담 증가, 그리고 현지 기업의 부상으로 신흥국 시장에는 비즈니스 기회가 있을 것으로 예측됩니다. 주요 기업들은 환자 모니터링 및 관리 개선을 위해 새로운 바이오마커 패널 및 휴대용 검사 장비 개발에 주력하고 있습니다.
본 조사의 주요 특징:
- 이 조사에서는 각 부문의 잠재적 수익 성장 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스를 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업의 경쟁 전략에 대한 중요한 인사이트를 제공합니다.
- 이 보고서는 세계 심장 바이오마커 시장의 주요 기업 프로파일을 작성하기 위해 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 재무 성과 및 전략 등 다양한 매개 변수를 기반으로 합니다.
- 이 보고서의 내용을 통해 기업의 마케팅 담당자와 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 대한 정보에 입각한 의사결정을 내릴 수 있을 것입니다.
- 이 세계 심장 바이오마커 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 시장 진출기업, 재무 분석가 등 업계의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 세계 심장 바이오마커 시장 분석에 사용되는 다양한 전략 매트릭스를 활용하여 의사결정을 쉽게 내릴 수 있을 것입니다.
목차
제1장 조사 목적과 전제조건
제2장 시장 전망
제3장 시장 역학, 규제 및 동향 분석
제4장 세계의 심장 바이오마커 시장 : 제품 유형별, 2021년-2033년
제5장 세계의 심장 바이오마커 시장 : 용도별, 2021년-2033년
제6장 세계의 심장 바이오마커 시장 : 검사 시행 장소별, 2021년-2033년
제7장 세계의 심장 바이오마커 시장 : 지역별, 2021년-2033년
제8장 경쟁 구도
제9장 애널리스트의 제안
제10장 참고 문헌 및 조사 방법
LSH 26.06.16Cardiac Biomarkers Market is estimated to be valued at USD 19.49 Bn in 2026 and is expected to reach USD 47.87 Bn by 2033, growing at a compound annual growth rate (CAGR) of 13.7% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 19.49 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 13.70% | 2033 Value Projection: | USD 47.87 Bn |
Cardiac biomarkers refer to proteins that are present in blood when the heart muscle is damaged or stressed. They help detect and monitor various heart conditions. The cardiac biomarkers market has been witnessing significant growth over the past few years driven by the rising incidence of cardiovascular diseases and growing elderly population worldwide who are more prone to cardiac issues. Furthermore, ongoing technological advancements are allowing for the development of more sensitive biomarkers that can enable the earlier detection of cardiac conditions.
Market Dynamics:
The global cardiac biomarkers market is driven by the increasing geriatric population, rising economic burden of cardiovascular diseases, growing adoption of point-of-care testing, and ongoing research & development. However, regulatory issues regarding the approval of new cardiac biomarkers, lack of awareness, and reluctant acceptance of new technologies pose challenges to market players. The market sees opportunities in developing economies due to increasing healthcare spending, growing diabetes and lifestyle disease burden, and emergence of local players. Key players are focusing on developing novel biomarker panels and portable testing devices for improved patient monitoring and management.
Key Features of the Study:
- It elucidates potential revenue growth opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global cardiac biomarkers market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Roche Diagnostics, Abbott Laboratories, Siemens Healthcare, bioMerieux, and Becton, Dickinson and Company.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global cardiac biomarkers market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac biomarkers market.
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Myocardial Muscle Creatine Kinase (CK MB)
- Myoglobin
- Troponins (T and I)
- Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Ischemia-modified Albumin (IMA)
- Others
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Myocardial Infarction
- Congestive Heart Failure
- Acute Coronary Syndrome
- Atherosclerosis
- Others
- Location of Testing Insights (Revenue, USD Bn, 2021 - 2033)
- Laboratory Testing
- Point of Care Testing
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Abbott Laboratories
- Life Diagnostics
- Roche Diagnostics
- Siemens Healthineers
- Danaher Corporation
- Becton, Dickinson and Company (BD)
- Bio-Rad Laboratories, Inc.
- Thermo Fisher Scientific Inc.
- PerkinElmer Inc.
- bioMerieux SA
- Randox Laboratories Ltd.
- Ortho Clinical Diagnostics
- Myriad RBM
- DiaDexus Inc.
- Response Biomedical Corp.
- BG Medicine, Inc.
- Boston Scientific Corporation
- Cardiovascular Systems, Inc.
- Quidel Corporation
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Product Type
- Market Snapshot, By Application
- Market Snapshot, By Location of Testing
- Market Snapshot, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- Acquisitions and Partnerships Scenario
- Funding and Investments
- PEST Analysis
- Porter's Analysis
4. Global Cardiac Biomarkers Market, By Product Type, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Myocardial Muscle Creatine Kinase (CK MB)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Myoglobin
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn) Myoglobin
- Troponins (T and I)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Brain Natriuretic Peptide (BNPs) or NT-proBNP
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Ischemia-modified Albumin (IMA)
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Cardiac Biomarkers Market, By Application, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Myocardial Infarction
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Congestive Heart Failure
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Acute Coronary Syndrome
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Atherosclerosis
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Cardiac Biomarkers Market, By Location of Testing, 2021 - 2033, (USD Bn)
- Overview
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
- Laboratory Testing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Point of Care Testing
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Cardiac Biomarkers Market, By Region, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 - 2033, (USD Bn)
- GCC
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Location of Testing, 2021 - 2033, (USD Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 - 2033, (USD Bn)
- North Africa
- Central Africa
- South Africa
8. Competitive Landscape
- Company Profiles
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Life Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Danaher Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Becton, Dickinson and Company (BD)
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bio-Rad Laboratories, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- PerkinElmer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- bioMerieux SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Randox Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Ortho Clinical Diagnostics
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Myriad RBM
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- DiaDexus Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Response Biomedical Corp.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BG Medicine, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Boston Scientific Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Cardiovascular Systems, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Quidel Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Abbott Laboratories
9. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
10. References and Research Methodology
- References
- Research Methodology
- About Us and Sales Contact
